Jane Street Group LLC Decreases Position in Assertio Holdings, Inc. (NASDAQ:ASRT)

Jane Street Group LLC reduced its position in shares of Assertio Holdings, Inc. (NASDAQ:ASRT) by 45.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,704 shares of the company’s stock after selling 58,980 shares during the period. Jane Street Group LLC owned 0.07% of Assertio worth $61,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Empowered Funds LLC boosted its stake in shares of Assertio by 5.4% in the fourth quarter. Empowered Funds LLC now owns 455,282 shares of the company’s stock worth $397,000 after acquiring an additional 23,369 shares during the last quarter. Palumbo Wealth Management LLC lifted its holdings in Assertio by 10.6% in the 4th quarter. Palumbo Wealth Management LLC now owns 205,598 shares of the company’s stock valued at $179,000 after purchasing an additional 19,637 shares in the last quarter. CM Management LLC boosted its stake in Assertio by 23.1% during the 4th quarter. CM Management LLC now owns 400,000 shares of the company’s stock worth $348,000 after purchasing an additional 75,000 shares during the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Assertio during the fourth quarter worth $53,000. Finally, Commonwealth Equity Services LLC purchased a new stake in shares of Assertio during the fourth quarter worth $30,000. Institutional investors and hedge funds own 48.96% of the company’s stock.

Analysts Set New Price Targets

ASRT has been the topic of a number of recent research reports. Industrial Alliance Securities set a $1.75 price target on shares of Assertio in a research report on Friday, March 14th. Wall Street Zen lowered shares of Assertio from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd. HC Wainwright restated a “buy” rating and issued a $3.50 price target on shares of Assertio in a research report on Monday, May 19th. Finally, Alliance Global Partners reaffirmed a “buy” rating on shares of Assertio in a report on Tuesday, May 13th.

Assertio Trading Up 1.5%

Shares of ASRT stock opened at $0.66 on Monday. The company has a current ratio of 2.01, a quick ratio of 1.57 and a debt-to-equity ratio of 0.30. Assertio Holdings, Inc. has a twelve month low of $0.51 and a twelve month high of $1.80. The company’s 50-day moving average price is $0.64 and its 200-day moving average price is $0.77. The stock has a market cap of $63.39 million, a price-to-earnings ratio of -0.91, a PEG ratio of 3.25 and a beta of 0.29.

Assertio (NASDAQ:ASRT) last posted its earnings results on Monday, May 12th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). Assertio had a negative net margin of 54.46% and a positive return on equity of 3.79%. The firm had revenue of $26.49 million during the quarter, compared to analyst estimates of $27.52 million. During the same quarter in the previous year, the firm earned $0.04 earnings per share. As a group, equities analysts predict that Assertio Holdings, Inc. will post -0.15 earnings per share for the current year.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.